Dr. Reddy's Laboratories Limited
RDY
$13.03
-$0.23-1.74%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -82.87% | -17.48% | -0.65% | -10.02% | 10.05% |
| Total Depreciation and Amortization | 0.75% | 1.15% | 3.90% | 5.83% | -5.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -65.46% | 230.44% | -132.69% | 326.24% | 134.74% |
| Change in Net Operating Assets | 183.89% | -211.57% | 69.41% | -1,518.66% | 105.91% |
| Cash from Operations | 35.10% | -31.35% | 4.35% | -32.73% | 224.25% |
| Capital Expenditure | 36.24% | -25.79% | 25.38% | 9.43% | -3.91% |
| Sale of Property, Plant, and Equipment | 1,378.18% | -91.09% | 236.99% | 423.72% | -108.79% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -396.17% | 20.40% | 64.88% | -214.74% | -338.30% |
| Cash from Investing | -142.40% | -5.70% | 51.26% | -45.96% | -137.80% |
| Total Debt Issued | -4.01% | 244.38% | 3,621.43% | 101.43% | -367.82% |
| Total Debt Repaid | -42.71% | -20.50% | 26.69% | -28.85% | 17.32% |
| Issuance of Common Stock | 163.33% | -67.39% | -53.06% | 1,681.82% | -56.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | 100.00% | -- | -- | -- |
| Other Financing Activities | -32.48% | 16.58% | 1.84% | -35.11% | 11.51% |
| Cash from Financing | -14.75% | 243.18% | -333.72% | 83.49% | -1,319.01% |
| Foreign Exchange rate Adjustments | 34.97% | 79.92% | 7.99% | -23.82% | 4,686.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -135.40% | 850.80% | 115.82% | -462.15% | -12.80% |